SNDL Correlations
SNDL Stock | USD 1.60 0.05 3.23% |
The current 90-days correlation between SNDL Inc and Canopy Growth Corp is 0.7 (i.e., Poor diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SNDL moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SNDL Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
SNDL Correlation With Market
Average diversification
The correlation between SNDL Inc and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SNDL Inc and DJI in the same portfolio, assuming nothing else is changed.
SNDL |
Moving together with SNDL Stock
0.77 | ME | 23Andme Holding | PairCorr |
0.83 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.76 | DNLI | Denali Therapeutics | PairCorr |
0.82 | VCEL | Vericel Corp Ord | PairCorr |
0.82 | VCYT | Veracyte | PairCorr |
0.72 | VERA | Vera Therapeutics | PairCorr |
0.67 | CDIOW | Cardio Diagnostics | PairCorr |
0.7 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.72 | VRAX | Virax Biolabs Group | PairCorr |
0.71 | VRDN | Viridian Therapeutics Downward Rally | PairCorr |
0.81 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.77 | VTRS | Viatris | PairCorr |
Moving against SNDL Stock
0.44 | VALN | Valneva SE ADR | PairCorr |
0.77 | DVAX | Dynavax Technologies | PairCorr |
0.68 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.6 | VRNA | Verona Pharma PLC | PairCorr |
0.43 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.38 | VSTM | Verastem | PairCorr |
0.33 | VNDA | Vanda Pharmaceuticals | PairCorr |
0.42 | EDSA | Edesa Biotech | PairCorr |
0.35 | EDIT | Editas Medicine | PairCorr |
0.35 | ELTX | Elicio Therapeutics | PairCorr |
Related Correlations Analysis
-0.16 | 0.0 | 0.44 | 0.93 | 0.91 | 0.84 | CGC | ||
-0.16 | 0.0 | 0.29 | -0.28 | -0.09 | 0.28 | ACB | ||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | HEXO | ||
0.44 | 0.29 | 0.0 | 0.42 | 0.35 | 0.54 | CRON | ||
0.93 | -0.28 | 0.0 | 0.42 | 0.85 | 0.74 | TLRY | ||
0.91 | -0.09 | 0.0 | 0.35 | 0.85 | 0.85 | OGI | ||
0.84 | 0.28 | 0.0 | 0.54 | 0.74 | 0.85 | CURLF | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between SNDL Stock performing well and SNDL Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SNDL's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CGC | 4.00 | (1.01) | 0.00 | (0.57) | 0.00 | 7.27 | 49.56 | |||
ACB | 3.82 | 0.33 | 0.11 | 0.91 | 3.31 | 6.36 | 53.14 | |||
HEXO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CRON | 1.74 | (0.03) | 0.05 | (0.01) | 1.86 | 3.59 | 13.50 | |||
TLRY | 3.89 | (0.79) | 0.00 | 4.00 | 0.00 | 8.65 | 25.07 | |||
OGI | 2.94 | (0.39) | 0.00 | (0.64) | 0.00 | 6.85 | 24.05 | |||
CURLF | 3.51 | (0.43) | 0.00 | (0.40) | 0.00 | 10.74 | 27.42 |
SNDL Corporate Management
Robbie Madan | Chief Officer | Profile | |
Matthew Husson | General Secretary | Profile | |
Alberto ParederoQuiros | Chief Officer | Profile | |
Phil McBride | Chief Officer | Profile | |
James Keough | Chief Officer | Profile | |
Zachary IV | CEO Director | Profile |